Related Experiment Videos
Experience with long-term outpatient venous access utilizing percutaneously placed silicone elastomer catheters
Cancer
|October 15, 1985
Summary
Percutaneously placed subclavian vein catheters offer a low-cost, safe option for long-term venous access in cancer patients. Catheter-related sepsis incidence was found to be minimal in this study.
Area of Science:
- Oncology
- Vascular Access
- Infectious Disease
Background:
- Chronic venous access is crucial for cancer patient treatment.
- Tunneled catheters are common but can be costly.
- Percutaneous subclavian catheters offer an alternative for venous access.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneously placed subclavian vein catheters for chronic venous access in cancer patients.
- To assess the incidence of catheter-related sepsis.
- To determine the cost-effectiveness compared to tunneled catheters.
Main Methods:
- A prospective study involving 140 consecutive cancer patients.
- Percutaneously placed subclavian vein catheters were used.
- Catheter dwell time was monitored for up to 882 days.
Main Results:
- The incidence of suspected and proven catheter-related sepsis was low.
- Catheters were successfully used for extended durations.
- No major complications were reported.
Conclusions:
- Percutaneous subclavian vein catheterization is a safe and effective method for chronic venous access in cancer patients.
- It presents a cost-effective alternative to tunneled catheter insertion.
- This approach minimizes the risk of catheter-related sepsis.